A decade review of mental health monitoring in clinical trials for United States Food and Drug Administration-approved genitourinary cancer treatments.

IF 3.7 2区医学 Q1 UROLOGY & NEPHROLOGY

BJU International Pub Date : 2025-06-15 DOI:10.1111/bju.16815

Farzad Teymouri,Parnian Jabbari,Omid Yazdanpanah,Aditya Mahadevan,Arash Rezazadeh Kalebasty,David J Benjamin

引用次数: 0

查看原文本刊更多论文

美国食品和药物管理局批准的泌尿生殖系统癌症治疗临床试验中心理健康监测的十年回顾。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BJU International 医学-泌尿学与肾脏学

CiteScore

9.10

自引率

4.40%

发文量

262

审稿时长

1 months

期刊介绍： BJUI is one of the most highly respected medical journals in the world, with a truly international range of published papers and appeal. Every issue gives invaluable practical information in the form of original articles, reviews, comments, surgical education articles, and translational science articles in the field of urology. BJUI employs topical sections, and is in full colour, making it easier to browse or search for something specific.